The cardiothoracic surgical team performed the world’s first Aeson bioprosthetic total artificial heart implantation in a female patient at UofL Health–Jewish Hospital. The investigational device is part of an Early Feasibility Study (EFS) sponsored by CARMAT, a French medical device company, in collaboration with the University of Louisville and the UofL Health–Trager Transplant Center. It …

The post appeared first on .